We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

May 28, 2020

Could Covid-19 be the opportunity that telehealth was waiting for?

Commentary
Kate O'Reilly
&

As little as 10 % of patients in the US reported using telehealth before the emergence of the novel coronavirus. However, as the world battles to contain the spread of Covid-19, the concept of digital healthcare is becoming an imminent reality. The Cleveland Clinic reported a dramatic increase in remote outpatient visits from a 2% low, to a colossal 75% over the period of March 7 to April 11. And we are witnessing comparable trends with digital health platforms across the board. The burning question is; is telehealth here to stay? Or is it a transient silver lining here to serve the healthcare communities during Covid-19?

Image Source: Sermo: https://sermo-mktg.s3.amazonaws.com/instapage/COVID+HCP+Sentiment_Updated+4.16.20.pdf

Telehealth is not a new phenomenon. However, there has been widespread resistance to its adoption and momentum has been slow. The WHO broadly define Telehealth as the "delivery of health care services, where patients and providers are separated by distance”.  Sounds familiar, doesn’t it? At a time where being “separated by distance” proves paramount to the protection of our communities, it is no wonder that the telehealth epoch has finally arrived. 

The rigor of regulatory and legal frameworks, combined with lack of reimbursements glare with notoriety when we consider the barriers to telehealth adoption. However, they are not the only ones. Prior to Covid-19, HCPs were typically not compensated for providing telehealth consultations the same way they were for face-to-face consultations. Many doctors and patients have also been reticent to revoke the traditional philosophies of medicine, which deem human touch essential. 

So, what has changed? Covid-19 is cutting through the red tape that initially restricted adoption of telehealth. It has forced the healthcare world to do a 180° on digital health, welcoming it with open arms. In the wake of Covid-19 telehealth is being leveraged to manage challenges facing healthcare systems, from mitigating hospital and emergency department overcrowding, to providing high quality medical consultations and monitoring to patients. The vast majority of hospitals in the US report a surge in the use and reliance on telehealth and expect to sustain increased levels of usage post-Covid.

Image Source: Lex Consulting Surveyhttps://www.lek.com/taxonomy/term/70

Both the CDC and WHO endorse the use of telehealth in official guidance addressing healthcare system operations during Covid-19. While telehealth historically faced myriad legal and regulatory challenges, emergency policy changes have been introduced to support its adoption. The US has seen an expansion in coverage across settings, waiving of co-payments and loosening of HIPAA requirements as part of its emergency response (coronavirus emergency legislation and CARES Act). Patients can now use telehealth services at any location, and physicians can now take on new patients in any state remotely. Loosening of privacy restrictions allow standard video conferencing apps such as FaceTime, Zoom and Skype to be used for telehealth, while they become compliant for health applications making them long term options. Prescribing guidelines for controlled substances have also been redacted so they can be prescribed during telehealth visits. Equipment for non-urgent injuries can also be prescribed remotely and shipped to patients with follow-up fitting consultations arranged online. 

Similar trends are happening across Europe. In France, reimbursement rules have been eased, and in Germany, the Health Innovation Hub has published a list of trusted telehealth providers. Having enacted its ‘just-in-time’ DVG (Digital Health Act) late last year, Germany was quick to lift restrictions on video consultations and allow more possibilities for psychotherapy video consultations, as well as the issuing of sick certificates without personal contact. In 2019 the British government unveiled its first long-term digital health plan proposing free mHealth to all UK citizens by 2023. In response to Covid-19 the NHS has requested GP surgeries to conduct as many remote consultations as possible.

In line with this seismic shift towards digital health it is of little surprise that there is strong investment in this area. Digital health venture funding documented a record $3.1 billion investment during the first quarter of 2020, according to Rock Health.

Image Source: https://hitconsultant.net/2019/04/02/rock-health-q1-2019-digital-health-funding/#.Xs6U3hNKhE4

Among the many interesting and exciting moves in this space include:

For more information on this space check out our Covid-19 digital solutions map, which is updated daily for more news and companies working to leverage telehealth as remote medicine becomes normality. https://www.healthxl.com/covid19.

Until a vaccine is developed, it’s likely that all of us will continue to proceed with caution, preferring services that mitigate risk and social interactions. As the industry begins to look forward to a world beyond (or alongside) the coronavirus, we envisage that healthcare will experience a "hybrid" reopening with urgent and essential services backtracking towards pre-Covid normality. The balance of in-person care and telecare is what we need to work out.

Telehealth is one of the rare sectors reaping a net positive effect of Covid-19. They say that “In the midst of every crisis lies a great opportunity” - Could Covid-19 be the opportunity telehealth has been waiting for?

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.